Clinical Trial Update: A Real-world, Prospective Observational Study of Rimegepant ODT for the Acute Treatment of Migraine Attacks in Adults.

View source ↗

Summary

Pfizer-sponsored real-world observational study evaluating the acute treatment of migraine attacks in adults with rimegepant ODT. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• NURTEC ODT (RIMEGEPANT SULFATE)

Snippet

Sponsor: Pfizer | Conditions: Migraine | Status: COMPLETED